ClinicalTrials.gov
ClinicalTrials.gov Menu

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00683358
Recruitment Status : Unknown
Verified January 2009 by Tokyo University.
Recruitment status was:  Active, not recruiting
First Posted : May 23, 2008
Last Update Posted : May 7, 2009
Sponsor:
Collaborator:
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Tokyo University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : April 2009
  Estimated Study Completion Date : April 2009

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 9, 2009 July 24, 2009
2 October 23, 2009 November 23, 2009
3 July 23, 2010 August 19, 2010
4 October 19, 2010 November 17, 2010
5 July 19, 2011  
6 July 20, 2011 August 15, 2011